Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
MCARH109 + MCARH125 for Multiple Myeloma
Recruiting1 awardPhase 1
Uniondale, New York
This trial will test the safety and effectiveness of two different experimental cancer therapies, MCARH109 and MCARH125. T cells will be taken from participants and sent to a lab, where they will be used to create the therapies. Then, participants will receive one of the therapies, either MCARH125 alone or with MCARH109.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service